Overview of Neutralizing Antibodies and Their Potential in COVID-19

被引:48
作者
Morales-Nunez, Jose Javier [1 ]
Munoz-Valle, Jose Francisco [1 ]
Torres-Hernandez, Paola Carolina [2 ]
Hernandez-Bello, Jorge [1 ]
机构
[1] Univ Guadalajara, Univ Ctr Hlth Sci CUCS, Inst Res Biomed Sci, Guadalajara 44340, Jalisco, Mexico
[2] Univ Guadalajara, Univ Ctr Hlth Sci CUCS, Immunol Lab, Guadalajara 44340, Jalisco, Mexico
关键词
neutralizing antibodies; SARS-CoV-2; neutralization assays; COVID-19; monoclonal antibodies; MEMORY B-CELLS; DEPENDENT ENHANCEMENT; VIRUS ENTRY; MEDIATED NEUTRALIZATION; MONOCLONAL-ANTIBODIES; AFFINITY MATURATION; SARS-COV-2; SPIKE; MECHANISMS; INFECTION; ASSAY;
D O I
10.3390/vaccines9121376
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The antibody response to respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a major focus of COVID-19 research due to its clinical relevance and importance in vaccine and therapeutic development. Neutralizing antibody (NAb) evaluations are useful for the determination of individual or herd immunity against SARS-CoV-2, vaccine efficacy, and humoral protective response longevity, as well as supporting donor selection criteria for convalescent plasma therapy. In the current manuscript, we review the essential concepts of NAbs, examining their concept, mechanisms of action, production, and the techniques used for their detection; as well as presenting an overview of the clinical use of antibodies in COVID-19.
引用
收藏
页数:22
相关论文
共 173 条
[1]   A simple protein-based surrogate neutralization assay for SARS-CoV-2 [J].
Abe, Kento T. ;
Li, Zhijie ;
Samson, Reuben ;
Samavarchi-Tehrani, Payman ;
Valcourt, Emelissa J. ;
Wood, Heidi ;
Budylowski, Patrick ;
Dupuis, Alan P. ;
Girardin, Roxie C. ;
Rathod, Bhavisha ;
Wang, Jenny H. ;
Barrios-Rodiles, Miriam ;
Colwill, Karen ;
McGeer, Allison J. ;
Mubareka, Samira ;
Gommerman, Jennifer L. ;
Durocher, Yves ;
Ostrowski, Mario ;
McDonough, Kathleen A. ;
Drebot, Michael A. ;
Drews, Steven J. ;
Rini, James M. ;
Gingras, Anne-Claude .
JCI INSIGHT, 2020, 5 (19)
[2]   B cell memory: building two walls of protection against pathogens [J].
Akkaya, Munir ;
Kwak, Kihyuck ;
Pierce, Susan K. .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (04) :229-238
[3]   Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms [J].
Ali, Amanat ;
Vijayan, Ranjit .
SCIENTIFIC REPORTS, 2020, 10 (01)
[4]   Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview [J].
Ali, Manasik Gumah ;
Zhang, Zhening ;
Gao, Qi ;
Pan, Mingzhu ;
Rowan, Edward G. ;
Zhang, Juan .
IMMUNOLOGIC RESEARCH, 2020, 68 (06) :325-339
[5]   Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination [J].
Altawalah, Haya .
VACCINES, 2021, 9 (08)
[6]   Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children [J].
Andabaka, Tea ;
Nickerson, Jason W. ;
Ximena Rojas-Reyes, Maria ;
David Rueda, Juan ;
Vrca, Vesna Bacic ;
Barsic, Bruno .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (04)
[7]   A perspective on potential antibody-dependent enhancement of SARS-CoV-2 [J].
Arvin, Ann M. ;
Fink, Katja ;
Schmid, Michael A. ;
Cathcart, Andrea ;
Spreafico, Roberto ;
Havenar-Daughton, Colin ;
Lanzavecchia, Antonio ;
Corti, Davide ;
Virgin, Herbert W. .
NATURE, 2020, 584 (7821) :353-363
[8]   Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection [J].
Astronomo, Rena D. ;
Santra, Sampa ;
Ballweber-Fleming, Lamar ;
Westerberg, Katharine G. ;
Mach, Linh ;
Hensley-McBain, Tiffany ;
Sutherland, Laura ;
Mildenberg, Benjamin ;
Morton, Georgeanna ;
Yates, Nicole L. ;
Mize, Gregory J. ;
Pollara, Justin ;
Hladik, Florian ;
Ochsenbauer, Christina ;
Denny, Thomas N. ;
Warrier, Ranjit ;
Rerks-Ngarm, Supachai ;
Pitisuttithum, Punnee ;
Nitayapan, Sorachai ;
Kaewkungwal, Jaranit ;
Ferrari, Guido ;
Shaw, George M. ;
Xia, Shi-Mao ;
Liao, Hua-Xin ;
Montefiori, David C. ;
Tomaras, Georgia D. ;
Haynes, Barton F. ;
McElrath, M. Juliana .
EBIOMEDICINE, 2016, 14 :97-111
[9]   SARS-CoV-2 structural features may explain limited neutralizing-antibody responses [J].
Bachmann, Martin F. ;
Mohsen, Mona O. ;
Zha, Lisha ;
Vogel, Monique ;
Speiser, Daniel E. .
NPJ VACCINES, 2021, 6 (01)
[10]   Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies [J].
Baum, Alina ;
Fulton, Benjamin O. ;
Wloga, Elzbieta ;
Copin, Richard ;
Pascal, Kristen E. ;
Russo, Vincenzo ;
Giordano, Stephanie ;
Lanza, Kathryn ;
Negron, Nicole ;
Ni, Min ;
Wei, Yi ;
Atwal, Gurinder S. ;
Murphy, Andrew J. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Kyratsous, Christos A. .
SCIENCE, 2020, 369 (6506) :1014-+